EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association between Alzheimer’s disease and metabolic syndrome: Unveiling the role of dyslipidemia mechanisms

Chenyu Yue, Yan Fu, Yongli Zhao, Yanan Ou, Yanping Sun, Lan Tan

Brain Network Disorders · 2025

DOI: 10.1016/j.bnd.2024.10.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Network Disorders, 2025. Verfasst von Chenyu Yue und 5 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD), the most common form of dementia, is characterized by progressive cognitive decline and memory problems. With a growing elderly population and limited treatment options, AD poses a significant social and economic burden. Several modifiable risk factors for AD have been identified, including diabetes, hypertension, obesity, and dyslipidemia . These factors often occur together, making it difficult to isolate their individual effects on health. As a result, they are grouped under the term metabolic syndrome (MetS). Interestingly, there appears to be a strong association between how the body processes lipids in MetS and the development of AD. This connection likely involves inflammation, oxidative stress , blood–brain barrier dysfunction, and the processing of amyloid precursor protein . However, the exact mechanisms remain unclear. This review aims to explore the potential role of MetS-related mechanisms, with a particular focus on how dyslipidemia contributes to AD development . Additionally, we will discuss potential therapeutic avenues targeting lipid pathways to offer future treatment options.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yue, C., Fu, Y., Zhao, Y., Ou, Y., Sun, Y., & Tan, L. (2025). Association between Alzheimer’s disease and metabolic syndrome: Unveiling the role of dyslipidemia mechanisms. Brain Network Disorders. https://doi.org/10.1016/j.bnd.2024.10.006

Vancouver

Yue C, Fu Y, Zhao Y, Ou Y, Sun Y, Tan L. Association between Alzheimer’s disease and metabolic syndrome: Unveiling the role of dyslipidemia mechanisms. Brain Network Disorders. 2025. doi:10.1016/j.bnd.2024.10.006

BibTeX
@article{Yue2025,
  author = {Yue, Chenyu and Fu, Yan and Zhao, Yongli and Ou, Yanan and Sun, Yanping and Tan, Lan},
  title = {Association between Alzheimer’s disease and metabolic syndrome: Unveiling the role of dyslipidemia mechanisms},
  journal = {Brain Network Disorders},
  year = {2025},
  doi = {10.1016/j.bnd.2024.10.006}
}
Kostenlos starten →